APOE and epilepsy: These elevations in the levels of both IL-1α mRNA and protein were accompanied by an APOE ε3,3 genotype-specific increase in βAPP expression in epilepsy patients compared to controls (APOE ε3,3 = 42 ± 11 vs APOE ε4,4 = 20 ± 11; and control = 21 ± 7; P = 0.03) (Figure 4E, F).